Bupropion for the treatment of methamphetamine dependence in non-daily users: A randomized, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Bupropion for the treatment of methamphetamine dependence in non-daily users: A randomized, double-blind, placebo-controlled trial

Published:2015-05 Issue: Volume:150 Page:170-174
ISSN:0376-8716
Container-title:Drug and Alcohol Dependence
language:en
Short-container-title:Drug and Alcohol Dependence

Author:

Anderson Ann L.^ORCID,Li Shou-Hua,Markova Denka,Holmes Tyson H.,Chiang Nora,Kahn Roberta,Campbell Jan,Dickerson Daniel L.^ORCID,Galloway Gantt P.,Haning William,Roache John D.,Stock Christopher^ORCID,Elkashef Ahmed M.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology,Toxicology

Reference19 articles.

1. Training raters to assess adult ADHD: reliability of ratings;Adler;J. Atten. Disord.,2005

2. Modafinil for the treatment of methamphetamine dependence;Anderson;Drug Alcohol Depend.,2012

3. Abuse of amphetamines and structural abnormalities in the brain;Berman;Ann. N. Y. Acad. Sci.,2008

4. Treatments for methamphetamine abuse: a literature review for the clinician;Brackins;J. Pharm. Pract.,2011

5. Bupropion for the treatment of methamphetamine dependence;Elkashef;Neuropsychopharmacology,2008

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Worsening trends in the frequency of methamphetamine and other stimulant use between treatment admission and discharge;Drug and Alcohol Dependence;2024-09

2. Trajectories of craving in the course of pharmacotherapy trials for methamphetamine use disorder;Addiction;2024-07-10

3. Extended observation of reduced methamphetamine use with combined naltrexone plus bupropion in the ADAPT‐2 trial;Addiction;2024-06-10

4. Reduced drug use as an alternative valid outcome in individuals with stimulant use disorders: Findings from 13 multisite randomized clinical trials;Addiction;2024-01-10

5. Disorders due to Substance Use: Stimulants;Tasman’s Psychiatry;2024